Global Peptide Therapeutics Market Size & Outlook, 2026-2033
Global peptide therapeutics market, 2021-2033 (US$M)
Related Markets
Global peptide therapeutics market highlights
- The global peptide therapeutics market generated a revenue of USD 140,857.0 million in 2025 and is expected to reach USD 294,582.4 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 8.7% by 2033.
- In terms of segment, metabolic disorders accounted for a revenue of USD 107,113.5 million in 2025.
- Metabolic disorders is the most lucrative application segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, China is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 140,857.0 million |
| Market revenue in 2033 | USD 294,582.4 million |
| Growth rate | 8.7% (CAGR from 2026 to 2033) |
| Largest segment | Metabolic disorders |
| Fastest growing segment | Metabolic disorders |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Gastrointestinal disorders, Cancer, Metabolic disorders, Cardiovascular disorders, Pain, Respiratory disorders, Infectious disease, Dermatological disorders, Renal disorders, Neurological disorders |
Other key industry trends
- In terms of revenue, the North America accounted for 62.0% of the global peptide therapeutics market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 14,090.3 million by 2033.
Metabolic disorders was the largest segment with a revenue share of 76.04% in 2025. Horizon Databook has segmented the Global peptide therapeutics market based on gastrointestinal disorders, cancer, metabolic disorders, cardiovascular disorders, pain, respiratory disorders, infectious disease, dermatological disorders, renal disorders, neurological disorders covering the revenue growth of each sub-segment from 2021 to 2033.
The global peptide therapeutics market is expected to grow at a lucrative rate over the forecast period as companies are focusing on the development of new drugs. Various companies are involved in extensive to develop novel drugs for treatment of target diseases to increase their market shares.
For instance, Sanofi is working on phase 3 clinical trials of Efpeglenatide, a long-lasting glucagon-like peptide-1 (GLP-1) diabetes molecule. The study is aimed at assessing the safety and efficacy of the treatment candidate. The in peptide therapeutics is majorly focused on metabolic disorders m followed by oncology and infectious diseases. This is expected to propel the market growth over the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Peptide Therapeutics Market Scope
Peptide Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Radius Health | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | http://www.radiuspharm.com |
| Ironwood Pharmaceuticals Inc Class A | View profile | 267 | 100 Summer Street, Suite 2300, Boston, MA, United States, 02110 | https://www.ironwoodpharma.com |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| Ipsen SA | View profile | 5325 | 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 | https://www.ipsen.com |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Global peptide therapeutics market size, by regions, 2021-2033 (US$M)
Top 10 countries: Peptide therapeutics market size, 2025 (US$M)
Global peptide therapeutics market share, by type of manufacturers, 2025 & 2033 (%, US$M)
Peptide therapeutics market: Opportunity assessment by country
Global peptide therapeutics market, by region, 2025 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
